Clinical Trials Directory

Trials / Unknown

UnknownNCT01417247

Renal Sympathetic Modification in Patients With Metabolic Syndrome

Renal Sympathetic Modification in Patients With Metabolic Syndrome.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with metabolic syndrome, and evaluate safety and efficacy of the intervention.

Detailed description

Metabolic syndrome is combination risk factors of serial cardiovascular and metabolic disease, included central obesity, insulin resistance, dyslipidemia, and hypertension. Basic studies suggested that sympathetic nerves over activity played an important role in the development and perpetuation of metabolic syndrome. Clinical therapies occurred by complication treatment and therapeutic life-style changes. Present study of renal ablation for sympathetic modification shows a new method to decrease sympathetic nerves activity. We assume that modifying renal sympathetic activity by ablation is effective and safe in treatment of metabolic syndrome. This trial is going to recruit 200 patients (Ablation group VS Control group = 1:1) with a follow-up duration of 3 years. Patients in ablation group will receive additional necessary medications besides expectant intervention, and patients in control group will receive appropriate medications only. We aim to observe the incident of composite cardiovascular events after renal sympathetic modification using THERMOCOOL® catheter in patients with hypertension, and evaluate safety and efficacy of the intervention.

Conditions

Interventions

TypeNameDescription
PROCEDURErenal sympathetic modificationDevice: THERMOCOOL® Catheter Renal sympathetic modification with a catheter-based procedure

Timeline

Start date
2011-08-01
Primary completion
2019-12-01
Completion
2020-06-01
First posted
2011-08-16
Last updated
2019-03-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01417247. Inclusion in this directory is not an endorsement.